GSKCONS
- Series
- EQ
- F&O
- No
- Status
- Inactive since 02 Apr 2019
Formerly SMITKLBECH (until 29 Jul 2003). Earlier name: Smithkline Beecham Consumer Healthcare Ltd. (until 29 Jul 2003).
Source: NSE equity master · as of 01 Apr 2019
- 03 Feb 2020 17:28PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 06 Nov 2019 13:18PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 03 Aug 2019 18:14PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 10 May 2019 19:07PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 13 Feb 2019 17:40PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 01 Nov 2018 09:54PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, the details of Analyst / Institutional Investors Meeting to be held on Friday, November 02, 2018 is as follows: Type of Meeting Time of Event Dial - in DetailsConference Call 1200 hours (IST) India +91 22 6280 1145/ +91 22 7115 8046 Hong Kong 800 964 448 Singapore 800 101 2045 UK 0 808 101 1573 USA 1 866 746 2133The above is for your information. Please t
- 15 Oct 2018 17:18PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesDear Sir / Madam,In reference to our intimation dated August 09, 2018 w.r.t. Schedule of Analyst, we wish to inform you that intimation was filed in time but was inadvertently given in the wrong letter head.The details of Analyst / Institutional Investors Meeting held on Thursday, August 9, 2018 is as follows: Type of Meeting Time of Event Dial - in DetailsConference Call 1100 hours (IST) India +91 22 6280 1145/ +91 22 7115 8046 Hong Kong 800 964 448 Singap
- 11 Sept 2018 10:17PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 09 Aug 2018 10:55PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, the details of Analyst / Institutional Investors Meeting to be held on Thursday, August 9, 2018 is as follows: Type of Meeting Time of Event Dial - in DetailsConference Call 1100 hours (IST) India +91 22 6280 1145/ +91 22 7115 8046 Hong Kong 800 964 448 Singapore 800 101 2045 UK 0 808 101 1573 USA 1 866 746 2133The above is for your information. Please t
- 09 May 2018 11:44PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 09 Feb 2018 10:46PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 03 Nov 2017 12:23PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 22 Sept 2017 15:07PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 10 May 2017 17:18PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates, the details of Analyst / Institutional Investors Meeting to be held on Friday, May 12, 2017 is as follows:Type of MeetingConference CallTime of Event1200 hours (IST)Dial - in DetailsMumbai: +91 22 3960 0611Bangalore, Chennai, Hyderabad, Kolkata, Gurugram (NCR), Cochin, Pune, Lucknow, Ahmedabad, Chandigarh 3940 3977*
- 10 Feb 2017 14:41PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call UpdatesAnalyst / Institutional Investors Meeting to be held on Tuesday, February 14, 2017 at 0930 hrs (IST); Dial in details are : Mumbai: +91 22 3960 0611 ; Bangalore, Chennai, Hyderabad, Kolkata : 3940 3977; Gurgaon (NCR), Cochin, Pune, Lucknow, Ahmedabad, Chandigarh: 3940 3977
- 07 Nov 2016 18:26PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates
- 13 May 2016 16:23PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the Schedule of Analyst / Institutional Investor meeting.
- 09 May 2016 15:47PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding Schedule of Analyst/ Institutional Investor Meeting.
- 11 Feb 2016 16:27PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has submitted to the Exchange a copy of Presentation to Analyst/ Institutional Investors
- 03 Feb 2016 13:51PDF · -Analyst meet
GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange vide letter February 03, 2016 regarding "Schedule of Analyst/Institutional Investor Meeting".
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries